Target intelligence / Profile preview

Systemic mineral pool

Molecular classification
Other
01

Overview

The systemic mineral pool represents the total body reservoir of essential minerals, including calcium, phosphorus, and magnesium, which are critical for skeletal integrity and cellular signaling [1]. This pool is not a single molecular entity but a physiological compartment maintained by the coordinated actions of the parathyroid glands, kidneys, intestines, and bone [1][2]. Hormonal regulators such as parathyroid hormone (PTH), 1,25-dihydroxyvitamin D, and fibroblast growth factor 23 (FGF23) manage the flux of minerals into and out of this pool to maintain serum concentrations within narrow physiological ranges [1][3]. In disease states like osteoporosis or chronic kidney disease-mineral and bone disorder (CKD-MBD), the balance of this pool is disrupted, leading to skeletal fragility or pathological calcification [3]. Therapeutic interventions target specific proteins, such as the Vitamin D Receptor (VDR) or the Calcium-Sensing Receptor (CaSR), to indirectly modulate the systemic mineral pool and restore homeostasis [2][3]. Consequently, while the pool itself is a physiological concept rather than a discrete protein, it serves as the primary endpoint for various pharmacological treatments aimed at metabolic bone and mineral disorders [1]. Monitoring the pool involves measuring serum electrolytes and bone turnover markers to ensure therapeutic efficacy and safety [1][3].

Other names
Mineral reservoirExtracellular mineral poolBone mineral poolBody mineral stores
02

Mechanism of action

Pharmacological agents modulate the systemic mineral pool by altering intestinal absorption, renal reabsorption, or the rate of bone resorption and formation [1][2].

03

Biological functions

Mineral homeostasisBone remodelingElectrolyte balanceAcid-base balanceSkeletal mineralization
04

Disease associations

OsteoporosisChronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)HypercalcemiaHypocalcemiaOsteomalacia
05

Safety considerations

HypercalcemiaHypocalcemiaVascular calcificationNephrolithiasisAdynamic bone disease
06

Interacting drugs

Calcium carbonate

6 more in the full profile.

07

Biomarkers

Serum calciumSerum phosphorusParathyroid hormone (PTH)25-hydroxyvitamin DC-terminal telopeptide (CTX)

Beyond the preview

Go deeper on Systemic mineral pool.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Systemic mineral pool.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call